Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-22-000317
Filing Date
2022-02-23
Accepted
2022-02-23 16:29:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 c103098_sc13ga.htm SC 13G/A 42488
  Complete submission text file 0000930413-22-000317.txt   43973
Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Subject) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91443 | Film No.: 22664201
SIC: 2834 Pharmaceutical Preparations